OSE Immunotherapeutics Stock
Stocks
OSE
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.184 EUR | -1.24% |
|
-4.10% | -38.17% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 74.89M 85.47M 69.52M 63.88M 120M 8.25B 122M 828M 324M 4.04B 321M 314M 13.94B | P/E 2026 * |
-2.45x | P/E 2027 * | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 116M 132M 107M 98.68M 186M 12.74B 189M 1.28B 501M 6.23B 496M 485M 21.53B | EV / Sales 2026 * |
23.6x | EV / Sales 2027 * | 13.1x |
| Free-Float |
74.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 day | -1.24% | ||
| 1 week | -4.10% | ||
| Current month | +2.18% | ||
| 1 month | -6.85% | ||
| 3 months | +4.60% | ||
| 6 months | -35.44% | ||
| Current year | -38.17% |
| 1 week | 3.15 |  | 3.25 |
| 1 month | 3.03 | | 3.91 |
| Current year | 2.87 | | 5.9 |
| 1 year | 2.87 | | 7.7 |
| 3 years | 2.7 | | 11.58 |
| 5 years | 2.7 | | 13.68 |
| 10 years | 2.7 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 2025-10-01 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 2025-08-19 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 2016-05-30 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 2017-06-13 |
| Director/Board Member | - | 2023-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/13/24 | Sell | Director | 30,000 | 0.1375% | ||
| 11/12/24 | Sell | Chief Administrative Officer | 10,000 | 0.0458% | ||
| 6/21/24 | Fiscal year | Director | 10,000 | 0.0459% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.24% | -4.10% | -37.57% | -7.71% | 86.51M | |
| -4.89% | -7.74% | -3.35% | +9.27% | 48.5B | |
| -0.14% | -0.76% | +378.26% | +583.71% | 38.97B | |
| +0.39% | +2.79% | +8.23% | +61.99% | 35.43B | |
| -1.54% | -4.01% | +5.95% | -13.03% | 33.65B | |
| -0.87% | -3.19% | -1.27% | +29.16% | 26.58B | |
| -1.28% | -6.20% | - | - | 16.82B | |
| -0.67% | -0.21% | +10.55% | +115.31% | 15.18B | |
| +1.32% | +1.85% | +11.40% | +15.52% | 13.89B | |
| +0.40% | -2.79% | +3.58% | -31.98% | 12.76B | |
| Average | -0.85% | -1.99% | +41.75% | +84.69% | 24.19B | |
| Weighted average by Cap. | -1.29% | -1.77% | +68.41% | +121.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.59M 4.55M 4.18M 7.88M 540M 7.99M 54.19M 21.21M 264M 20.99M 20.54M 912M | 10.53M 12.02M 9.78M 8.98M 16.93M 1.16B 17.18M 116M 45.58M 567M 45.11M 44.14M 1.96B |
| Net income | -30.59M -34.91M -28.39M -26.09M -49.17M -3.37B -49.89M -338M -132M -1.65B -131M -128M -5.69B | -21.47M -24.5M -19.93M -18.31M -34.51M -2.36B -35.02M -237M -92.92M -1.16B -91.97M -89.99M -4B |
| Net Debt | 40.79M 46.55M 37.87M 34.8M 65.57M 4.49B 66.54M 451M 177M 2.2B 175M 171M 7.59B | 63.08M 72M 58.56M 53.82M 101M 6.95B 103M 698M 273M 3.4B 270M 264M 11.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | €3.184 | -1.24% | 86,708 |
| 26-07-21 | €3.224 | +2.35% | 80,326 |
| 26-07-20 | €3.150 | -2.23% | 72,172 |
| 26-07-17 | €3.222 | -0.98% | 99,365 |
| 26-07-16 | €3.254 | -1.99% | 58,467 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
Select your edition
All financial news and data tailored to specific country editions
